Literature DB >> 2264856

Cotswolds modification of the Ann Arbor staging system for Hodgkin's disease.

C L Olweny.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2264856

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

1.  Prognostic Significance of IL-6 in Hodgkin Lymphoma.

Authors:  Sainath Bhethanabhotla; Akash Tiwari; M C Sharma; Sreenivas Vishnubhatla; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2019-03-04       Impact factor: 1.967

2.  Lymphoma associated hemophagocytic syndrome: A single-center retrospective study.

Authors:  Yu Chang; Meng Cui; Xiaorui Fu; Lijuan Han; Lei Zhang; Ling Li; Xin Li; Zhenchang Sun; Jingjing Wu; Xudong Zhang; Zhaoming Li; Feifei Nan; Jiaqin Yan; Guangyao Sheng; Mingzhi Zhang
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

3.  Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial.

Authors:  Lucia Zanoni; Alessandro Broccoli; Alessandro Lambertini; Cinzia Pellegrini; Vittorio Stefoni; Filippo Lodi; Cristina Fonti; Cristina Nanni; Pier Luigi Zinzani; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-17       Impact factor: 9.236

4.  18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reports.

Authors:  Alexandra Thomas; Roger D Gingrich; Brian J Smith; Laura Jacobus; Kay Ristow; Cristine Allmer; Matthew J Maurer; Thomas M Habermann; Brian K Link
Journal:  Leuk Lymphoma       Date:  2010-03

5.  Diagnosis of diffuse spleen involvement in haematological malignancies using a spleen-to-liver attenuation ratio on contrast-enhanced CT images.

Authors:  Christian Philipp Reinert; Clemens Hinterleitner; Jan Fritz; Konstantin Nikolaou; Marius Horger
Journal:  Eur Radiol       Date:  2018-06-18       Impact factor: 5.315

6.  An assessment of selected immune parameters of patients with Hodgkin's disease.

Authors:  Andrzej Kołtan; Sylwia Kołtan; Robert Dębski; Elżbieta Grześk; Mariusz Wysocki; Grzegorz Grześk
Journal:  Mol Clin Oncol       Date:  2014-09-19

7.  Myeloid growth factor therapy in malignant lymphomas--a 5-year retrospective study from Hungary.

Authors:  László Váróczy; Lajos Gergely; Edit Páyer; Zsófia Miltényi; Zsófia Simon; Arpád Illés
Journal:  Support Care Cancer       Date:  2010-09-04       Impact factor: 3.603

8.  A rare manifestation of a multisystemic disease: a case of vocal cord palsy secondary to sarcoidosis.

Authors:  Saleem Mastan; Rajeev Advani; Nicola Stobbs; Nirmal Kumar
Journal:  BMJ Case Rep       Date:  2015-04-26

9.  Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.

Authors:  Dlawer Abdulla Barzenje; Milada Cvancarova Småstuen; Knut Liestøl; Alexander Fosså; Jan Delabie; Arne Kolstad; Harald Holte
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

10.  Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CT.

Authors:  Cédric Rossi; Morgane Mounier; Pauline Brice; Violaine Safar; Emmanuelle Nicolas-Virelizier; Philippe Rey; Aspasia Stamatoullas-Bastard; Marion Alcantara; Adrien Chauchet; Emilie Reboursière; Lauriane Filliatre; Aurore Perrot; Sylvain Garciaz; Gilles Salles; Bertrand Coiffier; Hervé Ghesquières; René-Olivier Casasnovas
Journal:  Oncotarget       Date:  2017-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.